These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7554143)

  • 1. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin.
    Draijer R; Vaandrager AB; Nolte C; de Jonge HR; Walter U; van Hinsbergh VW
    Circ Res; 1995 Nov; 77(5):897-905. PubMed ID: 7554143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I.
    Smolenski A; Poller W; Walter U; Lohmann SM
    J Biol Chem; 2000 Aug; 275(33):25723-32. PubMed ID: 10851246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
    Meinecke M; Geiger J; Butt E; Sandberg M; Jahnsen T; Chakraborty T; Walter U; Jarchau T; Lohmann SM
    Mol Pharmacol; 1994 Aug; 46(2):283-90. PubMed ID: 8078490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells.
    Draijer R; Atsma DE; van der Laarse A; van Hinsbergh VW
    Circ Res; 1995 Feb; 76(2):199-208. PubMed ID: 7834830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
    Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
    Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes.
    Sporbert A; Mertsch K; Smolenski A; Haseloff RF; Schönfelder G; Paul M; Ruth P; Walter U; Blasig IE
    Brain Res Mol Brain Res; 1999 Apr; 67(2):258-66. PubMed ID: 10216224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP.
    Butt E; Nolte C; Schulz S; Beltman J; Beavo JA; Jastorff B; Walter U
    Biochem Pharmacol; 1992 Jun; 43(12):2591-600. PubMed ID: 1321624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
    Li Z; Ajdic J; Eigenthaler M; Du X
    Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
    Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
    Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells.
    Sandberg M; Butt E; Nolte C; Fischer L; Halbrügge M; Beltman J; Jahnsen T; Genieser HG; Jastorff B; Walter U
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):521-7. PubMed ID: 1659381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGMP-dependent protein kinase phosphorylates p21-activated kinase (Pak) 1, inhibiting Pak/Nck binding and stimulating Pak/vasodilator-stimulated phosphoprotein association.
    Fryer BH; Wang C; Vedantam S; Zhou GL; Jin S; Fletcher L; Simon MC; Field J
    J Biol Chem; 2006 Apr; 281(17):11487-95. PubMed ID: 16490784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets.
    Wentworth JK; Pula G; Poole AW
    Biochem J; 2006 Jan; 393(Pt 2):555-64. PubMed ID: 16197368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
    Eckert RE; Jones SL
    J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
    Oelze M; Mollnau H; Hoffmann N; Warnholtz A; Bodenschatz M; Smolenski A; Walter U; Skatchkov M; Meinertz T; Münzel T
    Circ Res; 2000 Nov; 87(11):999-1005. PubMed ID: 11090544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator-stimulated phosphoprotein deficiency potentiates PAR-1-induced increase in endothelial permeability in mouse lungs.
    Profirovic J; Han J; Andreeva AV; Neamu RF; Pavlovic S; Vogel SM; Walter U; Voyno-Yasenetskaya TA
    J Cell Physiol; 2011 May; 226(5):1255-64. PubMed ID: 20945373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading.
    Lawrence DW; Pryzwansky KB
    J Immunol; 2001 May; 166(9):5550-6. PubMed ID: 11313394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.
    Deguchi A; Soh JW; Li H; Pamukcu R; Thompson WJ; Weinstein IB
    Mol Cancer Ther; 2002 Aug; 1(10):803-9. PubMed ID: 12492113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the PKG substrate, vasodilator-stimulated phosphoprotein (VASP), in human cultured prostatic stromal cells.
    Cook AL; Haynes JM
    Nitric Oxide; 2007 Feb; 16(1):10-7. PubMed ID: 17049286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
    Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
    Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.